Table 3.
Comparison of select medical conditions and medication usage in classic Kaposi sarcoma (cKS) patients and Kaposi sarcoma-associated herpes virus (KSHV) seropositive controls.
| No. of cKS patients (n=142) | No. of KSHV seropositive controls (n=123) | OR (95% CI)* | |
|---|---|---|---|
| Medical Conditions | |||
| Allergies | 26 | 24 | 1.01 (0.50-2.07) |
| Angina | 9 | 7 | 0.76 (0.24-2.37) |
| Arthritis | 4 | 6 | 0.55 (0.13-2.39) |
| Asthma | 15 | 13 | 1.42 (0.61-3.31) |
| Bronchitis | 41 | 38 | 0.99 (0.54-1.83) |
| Chilblains | 38 | 28 | 1.11 (0.58-2.13) |
| Cirrhosis/Liver failure | 15 | 9 | 2.17 (0.73-6.41) |
| Diabetes | 45 | 15 | 4.73 (2.02-11.1) |
| Edema | 68 | 31 | 3.11 (1.59-6.05) |
| >5 years prior to interview | 34 | 18 | 1.63 (0.74-3.59) |
| Gout | 14 | 8 | 1.28 (0.45-3.62) |
| Heart disease/stroke | 43 | 31 | 0.93 (0.49-1.77) |
| Hypertension | 87 | 70 | 0.87 (0.48-1.56) |
| Kidney failure/Dialysis | 19 | 4 | 3.86 (1.22-12.3) |
| Malaria | 32 | 35 | 0.84 (0.45-1.58) |
| Sexually transmitted disease | 9 | 11 | 0.72 (0.26-1.93) |
| Thalassemia | 3 | 3 | 1.18 (0.18-7.55) |
| Medications† | |||
| Oral Cortisone | 53 | 26 | 2.34 (1.23-4.45) |
| Cortisone cream | 53 | 36 | 1.45 (0.79-2.66) |
| Other medicated non-steroid cream | 62 | 57 | 0.81 (0.45-1.46) |
| Herbal treatments | 26 | 16 | 1.58 (0.70-3.55) |
*
Logistic regression analyses adjusted for gender, age (<68, 68-74, 75-80, >80 years) and education (1st-4th grade, 5th grade and higher) that account of the sample weighting and the multistage stratified cluster sampling of the controls
†
Used during the past 10 years.